Protagenic Therapeutics, Inc.\New (PTIXW) — 10-Q Filings
All 10-Q filings from Protagenic Therapeutics, Inc.\New. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
Protagenic's Losses Mount Amid Restructuring, Cash Influx
— Nov 26, 2025 Risk: high
Protagenic Therapeutics, Inc. (PTIXW) reported a significant increase in net loss for the six months ended September 30, 2025, reaching $5,927,019, a substantia -
Protagenic Therapeutics Files Q1 2025 10-Q
— May 13, 2025 Risk: medium
Protagenic Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Atrinsic, Inc., is incorporated in Delaware an -
Protagenic Therapeutics Files Q3 2024 10-Q
— Nov 14, 2024 Risk: medium
Protagenic Therapeutics, Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Atrinsic, Inc. and NEW MOTION, INC., is in -
Protagenic Therapeutics Files Q2 2024 10-Q
— Aug 14, 2024 Risk: medium
Protagenic Therapeutics, Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as Atrinsic, Inc., is based in New York and operat -
Protagenic Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024
— May 15, 2024 Risk: low
Protagenic Therapeutics, Inc.\new (PTIXW) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Protagenic Therapeutics, Inc. filed a 10-Q report for th
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX